tilsotolimod Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Gustave Roussy, Cancer Campus, Grand Paris (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadadvanced melanoma

I am/have/hadneutrophil count

I am/have/hadendocrine disorder

I am/have/hadcancer

I am/have/hadcolorectal cancer

I am/have/hadadvanced cancer

I am/have/hadmetastasis

I am/have/hadconventional treatment

I am/have/hadEGFR

I am/have/hadcancer therapy

I am/have/hadgilbert's syndrome

I am/have/hadmetastatic melanoma

I am/have/hadstage iv non-small cell lung cancer

I am/have/hadblood transfusion

I am/have/hadmeasurable disease

I am/have/hadcancer treatment

I am/have/hadnon-small cell lung cancer

I am/have/hadhcg pregnancy test

I am/have/hadliver metastasis

I am/have/hadocular melanoma

added new label for I am/have/had

more

I am looking for

I am looking formelanoma

I am looking forbevacizumab

I am looking foripilimumab

I am looking formdx-ctla-4

I am looking forfluorouracil

I am looking fortumor markers

I am looking foririnotecan

I am looking foroxaliplatin

I am looking fortilsotolimod

I am looking fornivolumab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Intratumoral Tilsotolimod a TLR-9 Agonist Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers

Open label, phase Ib study of intratumoral tilsotolimod in combination with intratumoral ipilimumab and intravenous nivolumab. The trial will be divided into two parts: PART A: the first part will assess the safety of two regimen and will recruit patients with all types of injectable solid malignancies PART B: the …

advanced melanoma

neutrophil count

endocrine disorder

cancer

colorectal cancer

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.